A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease - Concepedia

Concepedia

Publication | Open Access

A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease

DOI Full Paper Access

48

Citations

30

References

2014

Year

Graham Naismith, L Smith, Sarah Barry, Joanna Munro, Susan Laird, Karen Rankin, Allan J. Morris, Jack Winter, Daniel R. Gaya

Journal of Crohn s and Colitis

Abstract

In this prospective dataset, FC is a useful tool to help identify quiescent Crohn's disease patients at a low risk of relapse over the ensuing 12 months. FC of 240 μg/g was the optimal cutoff in this cohort.

References

	Year	Citations
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. William R. Best, Jack M. Becktel, John W. Singleton, PubMed	1976	3.2K
Development of a Crohn's Disease Activity Index William R. Best, Jack M. Becktel, John W. Singleton, Gastroenterology Functional Gastrointestinal DisorderDisease Activity IndexGastroenterologyUlcerative ColitisEpidemiology	1976	3.1K
Long-Term Evolution of Disease Behavior of Crohn's Disease Jacques Cosnes, Stéphane Cattan, Antoine Blain, Inflammatory Bowel Diseases	2002	1.3K
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease Geert D’Haens, Marc Ferrante, Séverine Vermeire, Inflammatory Bowel Diseases	2012	797
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease Jeremy Tibble, G Sigthorsson, Steven Bridger, Gastroenterology InflammationChronic Inflammatory DiseasesAutoimmune DiseaseIntestinal InflammationMucosal Immunology	2000	760
Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices Jost Langhorst, Sigrid Elsenbruch, Julia Koelzer, The American Journal of Gastroenterology	2007	591
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped Édouard Louis, Jean–Yves Mary, Gwénola Vernier-Massouille, Gastroenterology InflammationAntimetabolite TherapyAnti-inflammatoryGastroenterologySurgery	2011	589
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI Alain Schoepfer, Christoph Beglinger, Alex Straumann, The American Journal of Gastroenterology	2009	564
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease Francesco Costa Gut	2005	550
A simple method for assessing intestinal inflammation in Crohn's disease J Tibble Gut	2000	495

Page 1